In an intubated patient with serotonin syndrome and rising peak airway pressures due to increased muscle tone, should dantrolene be used?

No, dantrolene should NOT be used for serotonin syndrome

Dantrolene is specifically indicated for malignant hyperthermia, not serotonin syndrome, and using it in this context represents a dangerous misapplication of therapy that could delay appropriate treatment and worsen outcomes.

Why This Distinction Matters

The rising peak airway pressures from increased muscle tone in serotonin syndrome have a fundamentally different pathophysiology than malignant hyperthermia:

• Serotonin syndrome causes muscle rigidity through excessive serotonergic activity in the central nervous system, leading to neuromuscular hyperactivity 1
• Malignant hyperthermia is a hypermetabolic reaction of skeletal muscle triggered by volatile anesthetics or succinylcholine, with dantrolene working by directly blocking calcium release from the sarcoplasmic reticulum 2, 3

Evidence Against Dantrolene in Serotonin Syndrome

The most recent comprehensive review explicitly states that there are no evidence-based drug treatments for serotonin syndrome 4. While dantrolene is the most effective evidence-based treatment for neuroleptic malignant syndrome, this distinction is critical—serotonin syndrome requires different management 4.

A 2024 review emphasizes that the cornerstone of treating severe serotonin syndrome does not lie in 'antidote' administration but in effective early resuscitative and supportive care 1. The evidence for serotonin antagonists like cyproheptadine lacks conclusive efficacy data 1.

Correct Management for Your Patient

For an intubated patient with serotonin syndrome and rising peak airway pressures:

1. Immediately discontinue all serotonergic agents - this is the primary treatment 1, 5

2. Aggressive supportive care:

   • Benzodiazepines (diazepam or midazolam) for agitation and muscle rigidity 5
   • Neuromuscular paralysis if benzodiazepines fail to control rigidity and ventilation becomes compromised 1, 5
   • Active cooling measures for hyperthermia 1
   • Sedation and mechanical ventilation optimization 1

3. Consider cyproheptadine (12-32 mg loading dose via nasogastric tube, then 8 mg every 6 hours) only as adjunctive therapy, recognizing the evidence is limited to case reports 5

Critical Pitfall to Avoid

Do not confuse serotonin syndrome with malignant hyperthermia or neuroleptic malignant syndrome. The single case report where dantrolene was used in serotonin syndrome 6 involved diagnostic confusion with neuroleptic malignant syndrome, and the patient's improvement likely resulted from supportive care and discontinuation of offending agents, not the dantrolene itself.

The Hunter Serotonin Toxicity Criteria can help confirm your diagnosis: presence of spontaneous clonus, inducible clonus with agitation/diaphoresis, ocular clonus with agitation/diaphoresis, tremor with hyperreflexia, or hypertonia with temperature >38°C and clonus 5.

Your immediate priority is benzodiazepines for muscle rigidity, not dantrolene. If benzodiazepines fail and ventilation remains compromised despite optimization, proceed to neuromuscular paralysis with vecuronium or similar agents 7.